Medications for Influenza A Virus

16 results

  • Amantadine (amantadine)

    (Amantadine)
    Coupler LLC
    Usage: Amantadine hydrochloride tablets are indicated for prophylaxis and treatment of influenza A virus infection, and for managing Parkinson's disease and drug-induced extrapyramidal reactions. They support immune response following vaccination and are used in early-stage influenza treatment, though not a substitute for vaccination.

  • Amantadine hydrochloride (amantadine hydrochloride)

    (amantadine hydrochloride)
    Graviti Pharmaceuticals Private Limited
    Usage: Amantadine Hydrochloride Tablets are indicated for prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. They are not a substitute for vaccination and are less effective than other Parkinson's treatments.

  • Amantadine hydrochloride (amantadine hydrochloride)

    (Amantadine Hydrochloride)
    Advagen Pharma Limited
    Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and is less effective than levodopa for Parkinson's disease.

  • Amantadine hydrochloride (amantadine hydrochloride)

    (Amantadine Hydrochloride)
    Bryant Ranch Prepack
    Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating Parkinson's disease, postencephalitic parkinsonism, and drug-induced extrapyramidal reactions. Early administration is recommended for effective treatment of influenza A.

  • Oseltamivir (oseltamivir)

    (OSELTAMIVIR)
    Alembic Pharmaceuticals Inc.
    Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.

  • Oseltamivir phosphate (oseltamivir phosphate)

    (Oseltamivir Phosphate)
    Neolpharma Inc
    Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. It is also used for prophylaxis of influenza in individuals 1 year and older.

  • Oseltamivir phosphate (oseltamivir phosphate)

    (Oseltamivir Phosphate)
    Asclemed USA, Inc.
    Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptoms. It is also indicated for prophylaxis of influenza A and B in patients 1 year and older.

  • Oseltamivir phosphate (oseltamivir phosphate)

    (Oseltamivir Phosphate)
    NuCare Pharmaceuticals,Inc.
    Usage: Oseltamivir Phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in patients aged 1 year and older. It is not a substitute for annual vaccinations.

  • Oseltamivir phosphate (oseltamivir phosphate)

    (Oseltamivir phosphate)
    Novadoz Pharmaceuticals LLC
    Usage: Oseltamivir phosphate capsules are indicated for the treatment of influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for annual influenza vaccination.

  • Oseltamivir phosphate (oseltamivir phosphate)

    (Oseltamivir Phosphate)
    Lupin Pharmaceuticals Inc
    Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual vaccination and has specific use limitations.